Case Reports
11 May 2025
Vol. 61 No. 3 (2009)
https://doi.org/10.4081/reumatismo.2009.212

Infliximab treatment in a case of rheumatoid scleromalacia perforans

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
1183
Views
952
Downloads

Authors

R. Herrera-Esparza
office@pagepress.org
E. Avalos-Diaz
Rheumatoid disease can cause ocular inflammation of the conjunctiva, sclera, and uveal tract. The sclera is an avascular layer covered by the episclera that is highly vascularised and can be affected by inflammation. Frequently, ophthalmic involvement in rheumatoid arthritis (RA) and spondyloartrhophaties results of a systemic and chronic inflammation that can produce devastating effects. Clinically, episcleritis looks similar to conjunctivitis, although there is no discharge. A common symptom of episcleritis is redness, and patients may also complain of foreign body...

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite



Infliximab treatment in a case of rheumatoid scleromalacia perforans. (2009). Reumatismo, 61(3), 212-215. https://doi.org/10.4081/reumatismo.2009.212

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.